1-8 of 8
Maccon M. Keane
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P5-16-08: Phase Ib/II trial evaluating safety and efficacy of copanlisib (PI3K inhibitor) and trastuzumab in pre-treated advanced HER2-positive breast cancer: Results from the PantHER study

Lisa Prior, Niamh M Keegan, Simon J Furney, Janice M Walshe, Giuseppe Gullo, John Crown, M John Kennedy, Diarmuid Smith, John McCaffrey, Catherine M Kelly, Keith Egan, Jennifer Kerr, Mark Given, Niall Sheehy, Peter O'Donovan, Andres Hernando, Ausra Teiserskiene, Imelda Parker, Elaine Kay, Ray McDermott, Maccon M Keane, Seamus O'Reilly, Liam Grogan, Oscar Breathnach, Patrick G Morris, Sinead Toomey, Bryan T Hennessy
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P5-16-08.
https://doi.org/10.1158/1538-7445.SABCS21-P5-16-08
Published: 15 February 2022
View article titled, Abstract P5-16-08: Phase Ib/II trial evaluating safety and efficacy of copanlisib (PI3K inhibitor) and trastuzumab in pre-treated advanced HER2-positive breast cancer: Results from the PantHER study
Journal Articles

Abstract PS4-23: An analysis of the clinical and economic impact of the 21-gene recurrence score (RS) in invasive lobular early-stage breast cancer (ESBC) in Ireland

Mehala Tharmabala, Lynda McSorley, Fathiya Al Rahbi, Evoy Denis, James G Geraghty, Rothwell Jane, Damian McCartan, Enda McDermott, Maccon M Keane, John Kennedy, Seamus O'Reilly, Steve Millen, John Crown, Lilian Mary Smyth, Catherine Margaret Kelly, Prichard Ruth, Cecily Quinn, Janice M Walshe
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS4-23.
https://doi.org/10.1158/1538-7445.SABCS20-PS4-23
Published: 15 February 2021
View article titled, Abstract PS4-23: An analysis of the clinical and economic impact of the 21-gene recurrence score (RS) in invasive lobular early-stage breast cancer (ESBC) in Ireland
Journal Articles

Abstract P1-19-24: A phase Ib trial of copanlisib in combination with trastuzumab in pretreated recurrent or metastatic HER2-positive breast cancer “PantHER”

Niamh M Keegan, Simon Furney, Janice Walshe, Giuseppe Gullo, John Kennedy, Kyran Bulger, John McCaffrey, Catherine M Kelly, Keith Egan, P O'Donovan, Andres Hernando, Ausra Teiserskiene, Imelda Parker, Angela M Farrelly, Aoife Carr, Giulio Calzaferri, Ray McDermott, Maccon M Keane, Liam Grogan, Oscar S Breathnach, Patrick G Morris, Sinead Toomey, Bryan T Hennessy
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P1-19-24.
https://doi.org/10.1158/1538-7445.SABCS19-P1-19-24
Published: 15 February 2020
View article titled, Abstract P1-19-24: A phase Ib trial of copanlisib in combination with trastuzumab in pretreated recurrent or metastatic HER2-positive breast cancer “PantHER”
Journal Articles

Abstract P1-10-11: Pathological complete response after carboplatin-based neoadjuvant chemotherapy in triple negative breast cancer: The importance of stromal tumor infiltrating lymphocytes as a predictive biomarker

Elaine M Walsh, Mark O'Loughlin, Aliaa Shalaby, Mark Webber, Michael J Kerin, Sharon A Glynn, Grace Callagy, Maccon M Keane
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P1-10-11.
https://doi.org/10.1158/1538-7445.SABCS19-P1-10-11
Published: 15 February 2020
View article titled, Abstract P1-10-11: Pathological complete response after carboplatin-based neoadjuvant chemotherapy in triple negative breast cancer: The importance of stromal tumor infiltrating lymphocytes as a predictive biomarker
Journal Articles

Down-Regulation of the erbB-2 Receptor by Trastuzumab (Herceptin) Enhances Tumor Necrosis Factor-related Apoptosis-inducing Ligand-mediated Apoptosis in Breast and Ovarian Cancer Cell Lines that Overexpress erbB-2

Mauricio Cuello, Seth A. Ettenberg, Amy S. Clark, Maccon M. Keane, Reuben H. Posner, Marion M. Nau, Phillip A. Dennis, Stan Lipkowitz
Journal: Cancer Research
Cancer Res (2001) 61 (12): 4892–4900.
Published: 01 June 2001
View article titled, Down-Regulation of the erbB-2 Receptor by Trastuzumab (Herceptin) Enhances Tumor Necrosis Factor-related Apoptosis-inducing Ligand-mediated Apoptosis in Breast and Ovarian Cancer Cell Lines that Overexpress erbB-2
Open the PDF for Down-Regulation of the erbB-2 Receptor by Trastuzumab (Herceptin) Enhances Tumor Necrosis Factor-related Apoptosis-inducing Ligand-mediated Apoptosis in Breast and Ovarian Cancer Cell Lines that Overexpress erbB-2 in another window
Journal Articles

Chemotherapy Augments TRAIL-induced Apoptosis in Breast Cell Lines

Maccon M. Keane, Seth A. Ettenberg, Marion M. Nau, Edward K. Russell, Stan Lipkowitz
Journal: Cancer Research
Cancer Res (1999) 59 (3): 734–741.
Published: 01 February 1999
View article titled, Chemotherapy Augments TRAIL-induced Apoptosis in Breast Cell Lines
Open the PDF for Chemotherapy Augments TRAIL-induced Apoptosis in Breast Cell Lines in another window
Journal Articles

Fas Expression and Function in Normal and Malignant Breast Cell Lines

Maccon M. Keane, Seth A. Ettenberg, Geoffrey A. Lowrey, Edward K. Russell, Stan Lipkowitz
Journal: Cancer Research
Cancer Res (1996) 56 (20): 4791–4798.
Published: 01 October 1996
View article titled, Fas Expression and Function in Normal and Malignant Breast Cell Lines
Open the PDF for Fas Expression and Function in Normal and Malignant Breast Cell Lines in another window
Journal Articles

The Protein Tyrosine Phosphatase DEP-1 Is Induced during Differentiation and Inhibits Growth of Breast Cancer Cells

Maccon M. Keane, Geoffrey A. Lowrey, Seth A. Ettenberg, Mark A. Dayton, Stan Lipkowitz
Journal: Cancer Research
Cancer Res (1996) 56 (18): 4236–4243.
Published: 01 September 1996
View article titled, The Protein Tyrosine Phosphatase DEP-1 Is Induced during Differentiation and Inhibits Growth of Breast Cancer Cells
Open the PDF for The Protein Tyrosine Phosphatase DEP-1 Is Induced during Differentiation and Inhibits Growth of Breast Cancer Cells in another window